PD‐L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single‐center retrospective study
European Journal of Clinical Investigation · 2026
DOI: 10.1111/eci.70124 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Gabriele Gaggero und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, IRCCS Giannina Gaslini Institute, Genoa, Italy. Hauptthemen laut MEDLINE: Meningioma, B7-H1 Antigen, Meningeal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Molecular expression of meningiomas has become increasingly important for predicting their biological behaviour. However, the factors influencing tumour recurrence and progression after surgery remain unclear. Recent studies suggest that programmed death‐ligand 1 ( PD ‐ L1 ) could be a key predictive and therapeutic factor in these tumours.
Methods
This single‐center retrospective study included 96 patients who underwent Simpson Grade I resection of intracranial meningiomas between 2001 and 2022. PD ‐ L1 expression was assessed immunohistochemically (clone SP142 ) and categorized as overall ( OE ), membranous (mb), granular cytoplasmic (gr) and perinuclear dot‐like. Associations with WHO grade, recurrence, mitotic count and Ki‐67 index were analysed using univariate and multivariate statistics.
Results
118 samples were analysed. Grade 2 meningiomas showed significantly higher mitotic count (4.0 ± 5.5 vs. 1.0 ± 1.0 n/mm 2 , p < .001) and Ki‐67 index (7.6 ± 2.1% vs. 3.5 ± .2%, p < .001) than Grade 1. PD ‐ L1 OE (2.0 ± 5.0% vs. .0 ± 1.0%, p < .001), gr (1.0 ± 2.5% vs. .0 ± 1.0%, p < .001) and mb (1.0 ± 1.0% vs. .0 ± .0%, p = .003) expressions were also higher in Grade 2. At recurrence, Grade 1 tumours progressing to Grade 2 showed increased PD ‐ L1 OE ( p = .025), gr ( p = .024) and mb ( p = .037). Multivariate analysis confirmed PD ‐ L1 gr and mb as independent markers of high‐grade tumours.
Conclusions
Granular cytoplasmic and membranous PD ‐ L1 expression patterns are significantly associated with tumour grade, recurrence and progression, suggesting their potential role as prognostic biomarkers in meningiomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, IRCCS Giannina Gaslini Institute, Genoa, Italy.
- Neurosurgery Unit, "Città Della Salute e Della Scienza" University Hospital, Turin, Italy.
- Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
- Division of Neurosurgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
ORCID-Profile: Alessandro Pesaresi, Valerio Vellone
Zitieren
APA
Gaggero, G., Pesaresi, A., Giunti, D., Bianconi, A., Truffelli, M., Grassi, M., Valle, L., Duzioni, S., Nozza, P., Dono, M., Anselmi, G., Zona, G., Vellone, V., & Fiaschi, P. (2026). PD‐L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single‐center retrospective study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70124
Vancouver
Gaggero G, Pesaresi A, Giunti D, Bianconi A, Truffelli M, Grassi M, et al. PD‐L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single‐center retrospective study. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70124
BibTeX
@article{Gaggero2026,
author = {Gaggero, Gabriele and Pesaresi, Alessandro and Giunti, Debora and Bianconi, Andrea and Truffelli, Monica and Grassi, Massimiliano and Valle, Luca and Duzioni, Sharon and Nozza, Paolo and Dono, Mariella and Anselmi, Giorgia and Zona, Gianluigi and Vellone, Valerio and Fiaschi, Pietro},
title = {PD‐L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single‐center retrospective study},
journal = {European Journal of Clinical Investigation},
year = {2026},
doi = {10.1111/eci.70124}
}
EUVIMED